CAS 2212020-52-3 występuje w naszej ofercie pod nazwami: Orforglipron/ 99.61% (existing batch purity), GLP–1 receptor agonist 1, Orforglipron, 3-[(1S,2S)-1-[2-[[(4S)-2-(4-Fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcyclopropyl]-1,2,4-oxadiazol-5(2H)-one, 98%, 98%, Orforglipron, 99.64%. Oferty producentów: TargetMol, GLPBio, Biosynth, Chemat, MedChemExpress. Dostępne opakowania: 1mg, 5mg, 10mg, 25mg, 50mg, 100mg, 25g, 50g.